DK158784A - Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa - Google Patents
Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa Download PDFInfo
- Publication number
- DK158784A DK158784A DK158784A DK158784A DK158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A DK 158784 A DK158784 A DK 158784A
- Authority
- DK
- Denmark
- Prior art keywords
- pseudomonas aeruginosa
- mucoid
- exopolysaccharid
- vaccine against
- against pseudomonas
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
- C12R2001/385—Pseudomonas aeruginosa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/874—Pseudomonas
- Y10S435/875—Pseudomonas aeruginosa
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/477,958 US4578458A (en) | 1983-03-23 | 1983-03-23 | Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa |
Publications (2)
Publication Number | Publication Date |
---|---|
DK158784D0 DK158784D0 (da) | 1984-03-19 |
DK158784A true DK158784A (da) | 1984-09-24 |
Family
ID=23898005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK158784A DK158784A (da) | 1983-03-23 | 1984-03-19 | Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa |
Country Status (7)
Country | Link |
---|---|
US (1) | US4578458A (de) |
EP (1) | EP0120532B1 (de) |
AT (1) | ATE52695T1 (de) |
AU (1) | AU571495B2 (de) |
CA (1) | CA1226543A (de) |
DE (1) | DE3482241D1 (de) |
DK (1) | DK158784A (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60248625A (ja) * | 1984-05-25 | 1985-12-09 | Mitsui Toatsu Chem Inc | 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途 |
AT384032B (de) * | 1985-01-14 | 1987-09-25 | Immuno Ag | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
US4693891A (en) * | 1985-09-09 | 1987-09-15 | Miles Laboratories, Inc. | Vaccine for Pseudomonas aeruginosa |
US5114712A (en) * | 1985-11-14 | 1992-05-19 | Mitsui Toatsu Chemicals, Inc. | Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection |
US5055455A (en) | 1988-09-28 | 1991-10-08 | Brigham And Women's Hospital | Capsular polysaccharide adhesin antigen, preparation, purification and use |
US5169840A (en) * | 1991-03-27 | 1992-12-08 | Nobipols Forskningsstiftelse | Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation |
US5233024A (en) * | 1991-04-09 | 1993-08-03 | The Brigham & Women's Hospital | Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use |
DE4204012A1 (de) * | 1992-02-12 | 1993-08-19 | Ulrich Prof Dr Zimmermann | Mitogenfreie substanz, deren herstellung und verwendung |
WO1994008617A1 (en) * | 1992-10-16 | 1994-04-28 | Brigham And Women's Hospital, Inc. | O-derivatized alginic acid antigens |
US5633234A (en) * | 1993-01-22 | 1997-05-27 | The Johns Hopkins University | Lysosomal targeting of immunogens |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
KR100397793B1 (ko) | 2000-07-28 | 2003-09-13 | 삼성전자주식회사 | 느릅나무로부터 분리된 신규의 미생물 및 그를 이용한항암 면역활성의 세포밖 당화합물의 제조방법 |
US7119172B2 (en) | 2001-05-21 | 2006-10-10 | The Brigham And Women's Hospital, Inc. | P. aeruginosa mucoid exopolysaccharide specific binding peptides |
US6962813B2 (en) * | 2001-05-21 | 2005-11-08 | The Brigham And Women's Hospital, Inc. | P. aeruginosa mucoid exopolysaccharide specific binding peptides |
NZ539153A (en) | 2002-11-12 | 2006-11-30 | Brigham & Womens Hospital | Polysaccharide vaccine for staphylococcal infections |
EP1583517B1 (de) * | 2002-11-12 | 2019-06-12 | The Brigham And Women's Hospital, Inc. | Verfahren und produkte zur behandlung von infektionen mit staphylokokken |
CA2508536A1 (en) * | 2002-12-04 | 2004-06-17 | Technologies Biolactis Inc. | An exopolysaccharides delivery system for active molecules |
AU2005236068C1 (en) | 2004-04-21 | 2012-08-30 | Beth Israel Deaconess Medical Center, Inc. | Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
AU2005286694A1 (en) * | 2004-09-21 | 2006-03-30 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to mannuronic acid specific binding peptides |
CA2646539A1 (en) * | 2006-03-23 | 2007-09-27 | Novartis Ag | Imidazoquinoxaline compounds as immunomodulators |
EP3312158A1 (de) | 2008-07-21 | 2018-04-25 | The Brigham and Women's Hospital, Inc. | Verfahren und zusammensetzungen in verbindung mit synthetischen beta-1,6 glucosamin-oligosacchariden |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2290219A1 (fr) * | 1974-11-05 | 1976-06-04 | Pasteur Institut | Principe actif de vaccin antipyocyanique |
US4285936A (en) * | 1979-12-10 | 1981-08-25 | The United States Of America As Represented By The Secretary Of The Army | Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa |
-
1983
- 1983-03-23 US US06/477,958 patent/US4578458A/en not_active Expired - Lifetime
-
1984
- 1984-03-09 AU AU25481/84A patent/AU571495B2/en not_active Ceased
- 1984-03-15 EP EP84200375A patent/EP0120532B1/de not_active Expired - Lifetime
- 1984-03-15 DE DE8484200375T patent/DE3482241D1/de not_active Expired - Fee Related
- 1984-03-15 AT AT84200375T patent/ATE52695T1/de not_active IP Right Cessation
- 1984-03-19 DK DK158784A patent/DK158784A/da not_active Application Discontinuation
- 1984-03-22 CA CA000450234A patent/CA1226543A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AU571495B2 (en) | 1988-04-21 |
CA1226543A (en) | 1987-09-08 |
ATE52695T1 (de) | 1990-06-15 |
EP0120532B1 (de) | 1990-05-16 |
DE3482241D1 (de) | 1990-06-21 |
AU2548184A (en) | 1984-09-27 |
EP0120532A2 (de) | 1984-10-03 |
US4578458A (en) | 1986-03-25 |
DK158784D0 (da) | 1984-03-19 |
EP0120532A3 (en) | 1985-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK158784A (da) | Mucoid exopolysaccharidvaccine mod pseudomonas aeruginosa | |
ES516354A0 (es) | "un metodo para aislar una bacteria del genero pseudomonas". | |
DK39991A (da) | Oral immunisering | |
SE8404707D0 (sv) | Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav | |
AU6750181A (en) | Vaccinal complex containing a specific antigen and vaccine containing it | |
ATE165515T1 (de) | Immuntoleranzinduzierendes agens | |
PL318930A1 (en) | Mutant enterotoxin effective as a non-toxic adjutant | |
ES2125901T3 (es) | Empleo de lipasas para la obtencion de medicamentos. | |
FI913275A0 (fi) | Foerfarande foer foerbaettring av sjukdomsmottstaondskraft. | |
AU2152988A (en) | Intranasal vaccination of horses with inactivated microorganisms or antigenic material | |
EP0306524A4 (de) | Von antikörpern, die unter verwendung eines eine beschränkte anzahl von antigenen präsentierenden pathogenen agens oder eines seiner derivate hergestellt worden sind, erkannte antigene determinanten. | |
EP0245433A4 (de) | Wichtigstes protein von neisseria gonorrhöe mit eisenregelung und dessen verwendung. | |
FI920356A0 (fi) | En biologisk preparation samt dess anvaendning. | |
FR2618910B1 (fr) | Methode et dispositif pour ameliorer le coefficient de transmission aux formations geologiques de l'energie creee par une source sismique de puits | |
LU90378I2 (fr) | Tetravac | |
DK0427462T3 (da) | Fremgangsmåde | |
EP0642333A4 (de) | Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion. | |
DE69429521D1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
EP0090660A3 (de) | Neisseria Gonorrhöe Vakzin | |
KR890700832A (ko) | 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체 | |
EP0189841A3 (en) | Enzymatic detection of bacterial capsular polysaccharide antigens | |
JPS5781416A (en) | Cilia of pseudomonas aeruginosa and method of using cilia as vaccine of pseudomonas aeruginosa infections | |
Szegli et al. | Gram-negative bacterial infection and acute knee joint arthritis. | |
EP0587765A4 (de) | Induktion der immunantwort gegen das tetanustoxin durch verarbeitung von mycobakterien, die das tetanustoxin oder fragmente davon exprimieren. | |
Sokalska et al. | Effect of Immunization With Extracellular Slime From Pseudomonas aeruginosa on Experimental Infection in Mice. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CTFF | Application for supplementary protection certificate (spc) filed |
Free format text: CA 1997 00029, 970716 |
|
CTFG | Supplementary protection certificate (spc) issued |
Free format text: CA 1997 00029, 970716, EXPIRES: 20001108 |
|
PUP | Patent expired | ||
AHS | Application shelved for other reasons than non-payment |